Search

Your search keyword '"S. Boselli"' showing total 68 results

Search Constraints

Start Over You searched for: Author "S. Boselli" Remove constraint Author: "S. Boselli"
68 results on '"S. Boselli"'

Search Results

1. FCC Physics Opportunities

2. Coronavirus disease 2019 in patients with neuroendocrine neoplasms

3. Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252]

4. HE-LHC: The High-Energy Large Hadron Collider Future Circular Collider Conceptual Design Report Volume 4

5. Report on the Physics at the HL-LHC, and Perspectives for the HE-LHC

6. INTENSIVE: InterNaTional rEgistry oN Sars-cov-2 posItiVe nEuroendocrine neoplasm patients

7. Higgs Physics at the HL-LHC and HE-LHC

8. Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial

9. Prospects for the determination of the top-quark Yukawa coupling at future $e^+e^-$ colliders

10. Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires—an Italian exploratory study

11. Higgs decay into four charged leptons in the presence of dimension-six operators

12. Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors

13. Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer

14. First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer

15. Higgs boson decay into four leptons at NLOPS electroweak accuracy

16. Routine laparoscopic cholecystectomy after endoscopic sphincterotomy for choledocholithiasis in octogenarians: is it worth the risk?

17. A patient-rated, surgeon-corrected scale for functional assessment after total anorectal reconstruction

18. Discriminant power and information content of Ranson's prognostic signs in acute pancreatitis: A meta-analytic study

19. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis

20. Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

21. Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination

22. Biofeedback therapy plus anal electrostimulation for fecal incontinence: prognostic factors and effects on anorectal physiology

23. Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer

24. Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma

25. Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents

26. Anorectal reconstruction by electrostimulated graciloplasty as part of abdominoperineal resection

27. Surgical results and functional outcome after total anorectal reconstruction by double graciloplasty supported by external-source electrostimulation and/or implantable pulse generators: an 8-year experience

28. Primary Anorectal Reconstruction after Abdominoperineal Excision by Coloperineal Pull-Through and Electrically Stimulated Graciloplasty: Efficiency and Limitations of a Hard-to-Catch-on Procedure

29. Rectal cancer in anorectal malformation with rectovestibular fistula: sphincter-restoring surgery by anterior resection and dynamic vaginoanograciloplasty

30. Diverticulitis of the caecum and ascending colon: an unavoidable diagnostic pitfall?

31. Subject Index Vol. 77, 2009

32. A 15-min premedication for 1-h paclitaxel infusion: Optimizing patients’ care

33. Double-gracilis anorectal neosphincter: technique of reconstruction after necrosis of the distal part of the muscles

34. [Method and application limitations of decision support systems in acute pancreatitis]

35. [Jejunal carcinoma: apropos 8 cases]

36. Continent perineal colostomy by electrostimulated graciloplasty in abdominoperineal resection. A preliminary report

37. [The prognostic evaluation of acute pancreatitis]

38. Combinations of the immunocytokine F16-IL2 with doxorubicin or with paclitaxel investigated in phase Ib studies in patients with advanced solid tumors

39. Carboplatin with etoposide in patients with extrapulmonary 'aggressive' neuroendocrine carcinoma

40. Abstract B55: Phase I/II study of the tumor-targeting human L19TNF-monoclonal antibody-cytokine fusion protein in patients with advanced solid tumors

41. 1228 Phase I study of NGR-hTNF, a vascular targeting agent (VTA), in combination withcisplatin in refractory patients (pts) with solid tumours

42. Phase Ib study of NGR-hTNF, a selective vascular targeting agent (VTA), in combination with cisplatin in patients with refractory solid tumors

43. [Gastric carcinoma in the elderly (clinical findings and results)]

44. A phase I study to define the optimal low dose of NGR-hTNF, a novel vascular targeting agent (VTA), in combination with cisplatin in patients (pts) with solid tumors

45. Erratum to'A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients' [Lung cancer 54 (2006) 359–364]

46. Thalidomide in patients with advanced hepatocellular carcinoma: A clinical/biological study

47. Epidermal growth factor receptor (EGFR) serum level may predict response in patients with advanced colorectal cancer (ACC) treated with gefitinib

48. First-line gefitinib combined with simplified FOLFOX-6 in patients with epidermal growth factor receptor-positive advanced colorectal cancer

49. Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.

50. Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA.

Catalog

Books, media, physical & digital resources